The study of L-FABP used as a biomarker of acute kidney injury (AKI) showed that urinary L-FABP elevation correlates with the severity of AKI, particularly in the early stages, and can be used for drug administration or tissue transplant monitoring [38, 39]. The gene discussed is FABP1; the disease is acute kidney injury.